nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Rivastigmine—Alzheimer's disease	0.164	0.432	CbGbCtD
Dantrolene—CYP3A4—Donepezil—Alzheimer's disease	0.131	0.345	CbGbCtD
Dantrolene—CYP3A4—Galantamine—Alzheimer's disease	0.0846	0.223	CbGbCtD
Dantrolene—RYR3—Alzheimers Disease—APBB1—Alzheimer's disease	0.0159	0.0786	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—BACE1—Alzheimer's disease	0.0159	0.0786	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—IDE—Alzheimer's disease	0.0159	0.0786	CbGpPWpGaD
Dantrolene—RYR3—forebrain—Alzheimer's disease	0.0143	0.183	CbGeAlD
Dantrolene—RYR3—telencephalon—Alzheimer's disease	0.0131	0.168	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—HSD17B10—Alzheimer's disease	0.00837	0.0413	CbGpPWpGaD
Dantrolene—Furazolidone—MAOB—Alzheimer's disease	0.00814	1	CrCbGaD
Dantrolene—RYR3—nervous system—Alzheimer's disease	0.00774	0.0992	CbGeAlD
Dantrolene—RYR3—central nervous system—Alzheimer's disease	0.00745	0.0955	CbGeAlD
Dantrolene—RYR3—cerebellum—Alzheimer's disease	0.00728	0.0933	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—CDK5—Alzheimer's disease	0.00634	0.0313	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—SNCA—Alzheimer's disease	0.00622	0.0307	CbGpPWpGaD
Dantrolene—RYR3—brain—Alzheimer's disease	0.00592	0.0758	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—PSEN1—Alzheimer's disease	0.00562	0.0277	CbGpPWpGaD
Dantrolene—RYR1—nervous system—Alzheimer's disease	0.00555	0.0712	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—PSENEN—Alzheimer's disease	0.00554	0.0273	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—APH1A—Alzheimer's disease	0.00547	0.027	CbGpPWpGaD
Dantrolene—RYR1—central nervous system—Alzheimer's disease	0.00534	0.0685	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—NCSTN—Alzheimer's disease	0.00532	0.0263	CbGpPWpGaD
Dantrolene—RYR1—cerebellum—Alzheimer's disease	0.00522	0.067	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—LRP1—Alzheimer's disease	0.00519	0.0256	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MME—Alzheimer's disease	0.00507	0.025	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—GAPDH—Alzheimer's disease	0.00463	0.0228	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MAPT—Alzheimer's disease	0.00436	0.0215	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—PSEN2—Alzheimer's disease	0.00433	0.0213	CbGpPWpGaD
Dantrolene—RYR1—brain—Alzheimer's disease	0.00424	0.0544	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—PPP3CA—Alzheimer's disease	0.00362	0.0179	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—YWHAQ—Alzheimer's disease	0.00344	0.017	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—APP—Alzheimer's disease	0.00339	0.0167	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—YWHAQ—Alzheimer's disease	0.00333	0.0164	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—GRIN2B—Alzheimer's disease	0.00323	0.0159	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—PLCB1—Alzheimer's disease	0.0032	0.0158	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—ADAM10—Alzheimer's disease	0.00291	0.0144	CbGpPWpGaD
Dantrolene—Coagulopathy—Rivastigmine—Alzheimer's disease	0.00276	0.00835	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00265	0.0131	CbGpPWpGaD
Dantrolene—Dysphonia—Rivastigmine—Alzheimer's disease	0.00262	0.00791	CcSEcCtD
Dantrolene—Nocturia—Donepezil—Alzheimer's disease	0.00261	0.00789	CcSEcCtD
Dantrolene—Speech disorder—Memantine—Alzheimer's disease	0.00256	0.00773	CcSEcCtD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—YWHAQ—Alzheimer's disease	0.00253	0.0125	CbGpPWpGaD
Dantrolene—Speech disorder—Rivastigmine—Alzheimer's disease	0.0025	0.00756	CcSEcCtD
Dantrolene—Atrioventricular block—Donepezil—Alzheimer's disease	0.0025	0.00755	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—YWHAQ—Alzheimer's disease	0.00246	0.0121	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—LPL—Alzheimer's disease	0.00243	0.012	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00237	0.0117	CbGpPWpGaD
Dantrolene—Urinary incontinence—Donepezil—Alzheimer's disease	0.00234	0.00707	CcSEcCtD
Dantrolene—Cardiac failure—Galantamine—Alzheimer's disease	0.00233	0.00703	CcSEcCtD
Dantrolene—Nocturia—Rivastigmine—Alzheimer's disease	0.00232	0.00701	CcSEcCtD
Dantrolene—Pain in extremity—Galantamine—Alzheimer's disease	0.00227	0.00686	CcSEcCtD
Dantrolene—Atrioventricular block—Memantine—Alzheimer's disease	0.00227	0.00685	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CRH—Alzheimer's disease	0.00224	0.0111	CbGpPWpGaD
Dantrolene—Respiratory failure—Memantine—Alzheimer's disease	0.00224	0.00677	CcSEcCtD
Dantrolene—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00222	0.00671	CcSEcCtD
Dantrolene—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00219	0.00662	CcSEcCtD
Dantrolene—Urinary retention—Galantamine—Alzheimer's disease	0.00216	0.00652	CcSEcCtD
Dantrolene—Urinary incontinence—Memantine—Alzheimer's disease	0.00212	0.00642	CcSEcCtD
Dantrolene—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.00208	0.00628	CcSEcCtD
Dantrolene—RYR3—Alzheimers Disease—CALM1—Alzheimer's disease	0.00204	0.0101	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—APOE—Alzheimer's disease	0.00204	0.01	CbGpPWpGaD
Dantrolene—Muscular weakness—Galantamine—Alzheimer's disease	0.002	0.00605	CcSEcCtD
Dantrolene—Dysphagia—Galantamine—Alzheimer's disease	0.00196	0.00593	CcSEcCtD
Dantrolene—Pulmonary oedema—Memantine—Alzheimer's disease	0.00196	0.00592	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00196	0.00965	CbGpPWpGaD
Dantrolene—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00192	0.00579	CcSEcCtD
Dantrolene—Phlebitis—Memantine—Alzheimer's disease	0.00185	0.0056	CcSEcCtD
Dantrolene—Thrombophlebitis—Memantine—Alzheimer's disease	0.00184	0.00557	CcSEcCtD
Dantrolene—Phlebitis—Rivastigmine—Alzheimer's disease	0.00181	0.00548	CcSEcCtD
Dantrolene—Pollakiuria—Galantamine—Alzheimer's disease	0.00181	0.00548	CcSEcCtD
Dantrolene—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.0018	0.00545	CcSEcCtD
Dantrolene—Cardiac failure—Donepezil—Alzheimer's disease	0.0018	0.00545	CcSEcCtD
Dantrolene—Hepatic failure—Memantine—Alzheimer's disease	0.00178	0.00537	CcSEcCtD
Dantrolene—RYR3—Alzheimers Disease—GSK3B—Alzheimer's disease	0.00176	0.0087	CbGpPWpGaD
Dantrolene—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00176	0.00532	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00174	0.0086	CbGpPWpGaD
Dantrolene—Depression—Galantamine—Alzheimer's disease	0.00174	0.00527	CcSEcCtD
Dantrolene—Renal failure—Galantamine—Alzheimer's disease	0.00172	0.0052	CcSEcCtD
Dantrolene—Urinary retention—Donepezil—Alzheimer's disease	0.00167	0.00505	CcSEcCtD
Dantrolene—Haematuria—Galantamine—Alzheimer's disease	0.00167	0.00504	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CRH—Alzheimer's disease	0.00165	0.00815	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00164	0.00809	CbGpPWpGaD
Dantrolene—Cardiac failure—Memantine—Alzheimer's disease	0.00164	0.00495	CcSEcCtD
Dantrolene—Cardiac failure—Rivastigmine—Alzheimer's disease	0.0016	0.00484	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.0016	0.00483	CcSEcCtD
Dantrolene—Pain in extremity—Memantine—Alzheimer's disease	0.0016	0.00483	CcSEcCtD
Dantrolene—Diplopia—Memantine—Alzheimer's disease	0.0016	0.00483	CcSEcCtD
Dantrolene—Haemoglobin—Galantamine—Alzheimer's disease	0.00158	0.00477	CcSEcCtD
Dantrolene—Haemorrhage—Galantamine—Alzheimer's disease	0.00157	0.00474	CcSEcCtD
Dantrolene—Hepatitis—Galantamine—Alzheimer's disease	0.00157	0.00474	CcSEcCtD
Dantrolene—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00156	0.00472	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00156	0.00472	CcSEcCtD
Dantrolene—Diplopia—Rivastigmine—Alzheimer's disease	0.00156	0.00472	CcSEcCtD
Dantrolene—Muscular weakness—Donepezil—Alzheimer's disease	0.00155	0.00469	CcSEcCtD
Dantrolene—Dysphagia—Donepezil—Alzheimer's disease	0.00152	0.00459	CcSEcCtD
Dantrolene—Urinary retention—Memantine—Alzheimer's disease	0.00152	0.00459	CcSEcCtD
Dantrolene—Visual impairment—Galantamine—Alzheimer's disease	0.00151	0.00457	CcSEcCtD
Dantrolene—Eosinophilia—Donepezil—Alzheimer's disease	0.00151	0.00455	CcSEcCtD
Dantrolene—Urinary retention—Rivastigmine—Alzheimer's disease	0.00149	0.00449	CcSEcCtD
Dantrolene—Flushing—Galantamine—Alzheimer's disease	0.00146	0.0044	CcSEcCtD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.00142	0.00702	CbGpPWpGaD
Dantrolene—Muscular weakness—Memantine—Alzheimer's disease	0.00141	0.00426	CcSEcCtD
Dantrolene—Pollakiuria—Donepezil—Alzheimer's disease	0.0014	0.00424	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00139	0.00688	CbGpPWpGaD
Dantrolene—Dysphagia—Memantine—Alzheimer's disease	0.00138	0.00417	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCG—Alzheimer's disease	0.00138	0.0068	CbGpPWpGaD
Dantrolene—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00138	0.00416	CcSEcCtD
Dantrolene—Depression—Donepezil—Alzheimer's disease	0.00135	0.00408	CcSEcCtD
Dantrolene—Dysphagia—Rivastigmine—Alzheimer's disease	0.00135	0.00408	CcSEcCtD
Dantrolene—Tension—Galantamine—Alzheimer's disease	0.00134	0.00405	CcSEcCtD
Dantrolene—Dysgeusia—Galantamine—Alzheimer's disease	0.00134	0.00404	CcSEcCtD
Dantrolene—Renal failure—Donepezil—Alzheimer's disease	0.00133	0.00403	CcSEcCtD
Dantrolene—Nervousness—Galantamine—Alzheimer's disease	0.00133	0.00401	CcSEcCtD
Dantrolene—Back pain—Galantamine—Alzheimer's disease	0.00132	0.004	CcSEcCtD
Dantrolene—Sweating—Donepezil—Alzheimer's disease	0.0013	0.00393	CcSEcCtD
Dantrolene—RYR3—Alzheimers Disease—IL1B—Alzheimer's disease	0.0013	0.00641	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP3—Alzheimer's disease	0.0013	0.00639	CbGpPWpGaD
Dantrolene—Haematuria—Donepezil—Alzheimer's disease	0.00129	0.00391	CcSEcCtD
Dantrolene—Vision blurred—Galantamine—Alzheimer's disease	0.00129	0.00389	CcSEcCtD
Dantrolene—Pollakiuria—Memantine—Alzheimer's disease	0.00128	0.00385	CcSEcCtD
Dantrolene—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00127	0.00383	CcSEcCtD
Dantrolene—Anaemia—Galantamine—Alzheimer's disease	0.00126	0.00382	CcSEcCtD
Dantrolene—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00125	0.00377	CcSEcCtD
Dantrolene—Malaise—Galantamine—Alzheimer's disease	0.00123	0.00372	CcSEcCtD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.00123	0.00607	CbGpPWpGaD
Dantrolene—Depression—Memantine—Alzheimer's disease	0.00123	0.00371	CcSEcCtD
Dantrolene—Haemoglobin—Donepezil—Alzheimer's disease	0.00122	0.0037	CcSEcCtD
Dantrolene—Hepatitis—Donepezil—Alzheimer's disease	0.00122	0.00368	CcSEcCtD
Dantrolene—Haemorrhage—Donepezil—Alzheimer's disease	0.00122	0.00368	CcSEcCtD
Dantrolene—Renal failure—Memantine—Alzheimer's disease	0.00121	0.00366	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00121	0.00596	CbGpPWpGaD
Dantrolene—Drowsiness—Rivastigmine—Alzheimer's disease	0.0012	0.00364	CcSEcCtD
Dantrolene—Depression—Rivastigmine—Alzheimer's disease	0.0012	0.00363	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CALM1—Alzheimer's disease	0.00119	0.00588	CbGpPWpGaD
Dantrolene—Convulsion—Galantamine—Alzheimer's disease	0.00118	0.00358	CcSEcCtD
Dantrolene—Renal failure—Rivastigmine—Alzheimer's disease	0.00118	0.00358	CcSEcCtD
Dantrolene—Hypertension—Galantamine—Alzheimer's disease	0.00118	0.00357	CcSEcCtD
Dantrolene—Haematuria—Memantine—Alzheimer's disease	0.00117	0.00355	CcSEcCtD
Dantrolene—Visual impairment—Donepezil—Alzheimer's disease	0.00117	0.00354	CcSEcCtD
Dantrolene—Myalgia—Galantamine—Alzheimer's disease	0.00116	0.00352	CcSEcCtD
Dantrolene—Sweating—Rivastigmine—Alzheimer's disease	0.00115	0.00349	CcSEcCtD
Dantrolene—Discomfort—Galantamine—Alzheimer's disease	0.00115	0.00347	CcSEcCtD
Dantrolene—Haematuria—Rivastigmine—Alzheimer's disease	0.00115	0.00347	CcSEcCtD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00114	0.00562	CbGpPWpGaD
Dantrolene—Dry mouth—Galantamine—Alzheimer's disease	0.00114	0.00344	CcSEcCtD
Dantrolene—Confusional state—Galantamine—Alzheimer's disease	0.00112	0.0034	CcSEcCtD
Dantrolene—Haemoglobin—Memantine—Alzheimer's disease	0.00111	0.00336	CcSEcCtD
Dantrolene—Haemorrhage—Memantine—Alzheimer's disease	0.0011	0.00334	CcSEcCtD
Dantrolene—Hepatitis—Memantine—Alzheimer's disease	0.0011	0.00334	CcSEcCtD
Dantrolene—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00109	0.0033	CcSEcCtD
Dantrolene—Chills—Donepezil—Alzheimer's disease	0.00109	0.0033	CcSEcCtD
Dantrolene—Tachycardia—Galantamine—Alzheimer's disease	0.00109	0.00329	CcSEcCtD
Dantrolene—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00109	0.00328	CcSEcCtD
Dantrolene—Hepatitis—Rivastigmine—Alzheimer's disease	0.00108	0.00327	CcSEcCtD
Dantrolene—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00108	0.00327	CcSEcCtD
Dantrolene—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00108	0.00326	CcSEcCtD
Dantrolene—Visual impairment—Memantine—Alzheimer's disease	0.00106	0.00322	CcSEcCtD
Dantrolene—Anorexia—Galantamine—Alzheimer's disease	0.00106	0.00321	CcSEcCtD
Dantrolene—Erythema—Donepezil—Alzheimer's disease	0.00106	0.0032	CcSEcCtD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.00105	0.00517	CbGpPWpGaD
Dantrolene—Visual impairment—Rivastigmine—Alzheimer's disease	0.00104	0.00315	CcSEcCtD
Dantrolene—Tension—Donepezil—Alzheimer's disease	0.00104	0.00314	CcSEcCtD
Dantrolene—Dysgeusia—Donepezil—Alzheimer's disease	0.00104	0.00313	CcSEcCtD
Dantrolene—Nervousness—Donepezil—Alzheimer's disease	0.00103	0.00311	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00103	0.00507	CbGpPWpGaD
Dantrolene—Flushing—Memantine—Alzheimer's disease	0.00103	0.0031	CcSEcCtD
Dantrolene—Back pain—Donepezil—Alzheimer's disease	0.00102	0.0031	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CREB1—Alzheimer's disease	0.00102	0.00503	CbGpPWpGaD
Dantrolene—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00102	0.00307	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCG—Alzheimer's disease	0.00102	0.00501	CbGpPWpGaD
Dantrolene—Insomnia—Galantamine—Alzheimer's disease	0.00101	0.00305	CcSEcCtD
Dantrolene—Flushing—Rivastigmine—Alzheimer's disease	0.001	0.00303	CcSEcCtD
Dantrolene—Vision blurred—Donepezil—Alzheimer's disease	0.000998	0.00302	CcSEcCtD
Dantrolene—Somnolence—Galantamine—Alzheimer's disease	0.000992	0.003	CcSEcCtD
Dantrolene—Chills—Memantine—Alzheimer's disease	0.000991	0.003	CcSEcCtD
Dantrolene—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000983	0.00297	CcSEcCtD
Dantrolene—Dyspepsia—Galantamine—Alzheimer's disease	0.000982	0.00297	CcSEcCtD
Dantrolene—Anaemia—Donepezil—Alzheimer's disease	0.000979	0.00296	CcSEcCtD
Dantrolene—Chills—Rivastigmine—Alzheimer's disease	0.00097	0.00293	CcSEcCtD
Dantrolene—Decreased appetite—Galantamine—Alzheimer's disease	0.00097	0.00293	CcSEcCtD
Dantrolene—CYP3A4—nervous system—Alzheimer's disease	0.000965	0.0124	CbGeAlD
Dantrolene—Fatigue—Galantamine—Alzheimer's disease	0.000962	0.00291	CcSEcCtD
Dantrolene—Malaise—Donepezil—Alzheimer's disease	0.000955	0.00289	CcSEcCtD
Dantrolene—Constipation—Galantamine—Alzheimer's disease	0.000954	0.00288	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000951	0.00469	CbGpPWpGaD
Dantrolene—Tension—Memantine—Alzheimer's disease	0.000944	0.00285	CcSEcCtD
Dantrolene—RYR3—Alzheimers Disease—TNF—Alzheimer's disease	0.000942	0.00465	CbGpPWpGaD
Dantrolene—Dysgeusia—Memantine—Alzheimer's disease	0.000942	0.00285	CcSEcCtD
Dantrolene—Erythema—Rivastigmine—Alzheimer's disease	0.000941	0.00284	CcSEcCtD
Dantrolene—Nervousness—Memantine—Alzheimer's disease	0.000934	0.00282	CcSEcCtD
Dantrolene—Back pain—Memantine—Alzheimer's disease	0.00093	0.00281	CcSEcCtD
Dantrolene—CYP3A4—central nervous system—Alzheimer's disease	0.000929	0.0119	CbGeAlD
Dantrolene—Tension—Rivastigmine—Alzheimer's disease	0.000923	0.00279	CcSEcCtD
Dantrolene—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000921	0.00278	CcSEcCtD
Dantrolene—Feeling abnormal—Galantamine—Alzheimer's disease	0.000919	0.00278	CcSEcCtD
Dantrolene—Convulsion—Donepezil—Alzheimer's disease	0.000918	0.00277	CcSEcCtD
Dantrolene—Hypertension—Donepezil—Alzheimer's disease	0.000914	0.00276	CcSEcCtD
Dantrolene—Nervousness—Rivastigmine—Alzheimer's disease	0.000914	0.00276	CcSEcCtD
Dantrolene—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000912	0.00276	CcSEcCtD
Dantrolene—Back pain—Rivastigmine—Alzheimer's disease	0.00091	0.00275	CcSEcCtD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.000907	0.00448	CbGpPWpGaD
Dantrolene—Vision blurred—Memantine—Alzheimer's disease	0.000906	0.00274	CcSEcCtD
Dantrolene—Myalgia—Donepezil—Alzheimer's disease	0.000902	0.00273	CcSEcCtD
Dantrolene—Ill-defined disorder—Memantine—Alzheimer's disease	0.000892	0.0027	CcSEcCtD
Dantrolene—Discomfort—Donepezil—Alzheimer's disease	0.000891	0.00269	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS3—Alzheimer's disease	0.00089	0.00439	CbGpPWpGaD
Dantrolene—Anaemia—Memantine—Alzheimer's disease	0.000889	0.00269	CcSEcCtD
Dantrolene—Vision blurred—Rivastigmine—Alzheimer's disease	0.000887	0.00268	CcSEcCtD
Dantrolene—Dry mouth—Donepezil—Alzheimer's disease	0.000882	0.00267	CcSEcCtD
Dantrolene—Abdominal pain—Galantamine—Alzheimer's disease	0.000882	0.00266	CcSEcCtD
Dantrolene—Body temperature increased—Galantamine—Alzheimer's disease	0.000882	0.00266	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CALM1—Alzheimer's disease	0.000879	0.00434	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000875	0.00432	CbGpPWpGaD
Dantrolene—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000873	0.00264	CcSEcCtD
Dantrolene—Confusional state—Donepezil—Alzheimer's disease	0.000872	0.00263	CcSEcCtD
Dantrolene—Anaemia—Rivastigmine—Alzheimer's disease	0.00087	0.00263	CcSEcCtD
Dantrolene—Malaise—Memantine—Alzheimer's disease	0.000867	0.00262	CcSEcCtD
Dantrolene—Leukopenia—Memantine—Alzheimer's disease	0.000861	0.0026	CcSEcCtD
Dantrolene—Malaise—Rivastigmine—Alzheimer's disease	0.000848	0.00256	CcSEcCtD
Dantrolene—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000846	0.00256	CcSEcCtD
Dantrolene—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000836	0.00253	CcSEcCtD
Dantrolene—Convulsion—Memantine—Alzheimer's disease	0.000833	0.00252	CcSEcCtD
Dantrolene—RYR3—Alzheimers Disease—TP53—Alzheimer's disease	0.000831	0.0041	CbGpPWpGaD
Dantrolene—Hypertension—Memantine—Alzheimer's disease	0.00083	0.00251	CcSEcCtD
Dantrolene—Anorexia—Donepezil—Alzheimer's disease	0.000824	0.00249	CcSEcCtD
Dantrolene—Hypersensitivity—Galantamine—Alzheimer's disease	0.000822	0.00248	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000819	0.00404	CbGpPWpGaD
Dantrolene—Myalgia—Memantine—Alzheimer's disease	0.000819	0.00247	CcSEcCtD
Dantrolene—Convulsion—Rivastigmine—Alzheimer's disease	0.000815	0.00246	CcSEcCtD
Dantrolene—Hypertension—Rivastigmine—Alzheimer's disease	0.000812	0.00245	CcSEcCtD
Dantrolene—Discomfort—Memantine—Alzheimer's disease	0.000809	0.00244	CcSEcCtD
Dantrolene—Myalgia—Rivastigmine—Alzheimer's disease	0.000801	0.00242	CcSEcCtD
Dantrolene—Dry mouth—Memantine—Alzheimer's disease	0.000801	0.00242	CcSEcCtD
Dantrolene—Asthenia—Galantamine—Alzheimer's disease	0.0008	0.00242	CcSEcCtD
Dantrolene—Confusional state—Memantine—Alzheimer's disease	0.000791	0.00239	CcSEcCtD
Dantrolene—Discomfort—Rivastigmine—Alzheimer's disease	0.000791	0.00239	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000788	0.00238	CcSEcCtD
Dantrolene—Dry mouth—Rivastigmine—Alzheimer's disease	0.000783	0.00237	CcSEcCtD
Dantrolene—Insomnia—Donepezil—Alzheimer's disease	0.000782	0.00236	CcSEcCtD
Dantrolene—Confusional state—Rivastigmine—Alzheimer's disease	0.000774	0.00234	CcSEcCtD
Dantrolene—Somnolence—Donepezil—Alzheimer's disease	0.000768	0.00232	CcSEcCtD
Dantrolene—Thrombocytopenia—Memantine—Alzheimer's disease	0.000768	0.00232	CcSEcCtD
Dantrolene—Tachycardia—Memantine—Alzheimer's disease	0.000766	0.00231	CcSEcCtD
Dantrolene—Diarrhoea—Galantamine—Alzheimer's disease	0.000763	0.00231	CcSEcCtD
Dantrolene—Dyspepsia—Donepezil—Alzheimer's disease	0.000761	0.0023	CcSEcCtD
Dantrolene—Hyperhidrosis—Memantine—Alzheimer's disease	0.000759	0.00229	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—Alzheimer's disease	0.000757	0.00374	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CREB1—Alzheimer's disease	0.000752	0.00371	CbGpPWpGaD
Dantrolene—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000752	0.00227	CcSEcCtD
Dantrolene—Decreased appetite—Donepezil—Alzheimer's disease	0.000751	0.00227	CcSEcCtD
Dantrolene—Tachycardia—Rivastigmine—Alzheimer's disease	0.000749	0.00226	CcSEcCtD
Dantrolene—Anorexia—Memantine—Alzheimer's disease	0.000748	0.00226	CcSEcCtD
Dantrolene—Fatigue—Donepezil—Alzheimer's disease	0.000745	0.00225	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000744	0.00367	CbGpPWpGaD
Dantrolene—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000742	0.00224	CcSEcCtD
Dantrolene—Constipation—Donepezil—Alzheimer's disease	0.000739	0.00223	CcSEcCtD
Dantrolene—Pain—Donepezil—Alzheimer's disease	0.000739	0.00223	CcSEcCtD
Dantrolene—Dizziness—Galantamine—Alzheimer's disease	0.000738	0.00223	CcSEcCtD
Dantrolene—Anorexia—Rivastigmine—Alzheimer's disease	0.000732	0.00221	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000715	0.00216	CcSEcCtD
Dantrolene—Feeling abnormal—Donepezil—Alzheimer's disease	0.000712	0.00215	CcSEcCtD
Dantrolene—Insomnia—Memantine—Alzheimer's disease	0.00071	0.00215	CcSEcCtD
Dantrolene—Vomiting—Galantamine—Alzheimer's disease	0.000709	0.00214	CcSEcCtD
Dantrolene—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000707	0.00214	CcSEcCtD
Dantrolene—Rash—Galantamine—Alzheimer's disease	0.000703	0.00213	CcSEcCtD
Dantrolene—Dermatitis—Galantamine—Alzheimer's disease	0.000703	0.00212	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0007	0.00211	CcSEcCtD
Dantrolene—Headache—Galantamine—Alzheimer's disease	0.000699	0.00211	CcSEcCtD
Dantrolene—Somnolence—Memantine—Alzheimer's disease	0.000698	0.00211	CcSEcCtD
Dantrolene—Insomnia—Rivastigmine—Alzheimer's disease	0.000694	0.0021	CcSEcCtD
Dantrolene—Dyspepsia—Memantine—Alzheimer's disease	0.000691	0.00209	CcSEcCtD
Dantrolene—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000691	0.00341	CbGpPWpGaD
Dantrolene—Urticaria—Donepezil—Alzheimer's disease	0.000687	0.00208	CcSEcCtD
Dantrolene—Abdominal pain—Donepezil—Alzheimer's disease	0.000683	0.00207	CcSEcCtD
Dantrolene—Body temperature increased—Donepezil—Alzheimer's disease	0.000683	0.00207	CcSEcCtD
Dantrolene—Somnolence—Rivastigmine—Alzheimer's disease	0.000683	0.00206	CcSEcCtD
Dantrolene—Decreased appetite—Memantine—Alzheimer's disease	0.000682	0.00206	CcSEcCtD
Dantrolene—Fatigue—Memantine—Alzheimer's disease	0.000677	0.00204	CcSEcCtD
Dantrolene—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000676	0.00204	CcSEcCtD
Dantrolene—Pain—Memantine—Alzheimer's disease	0.000671	0.00203	CcSEcCtD
Dantrolene—Constipation—Memantine—Alzheimer's disease	0.000671	0.00203	CcSEcCtD
Dantrolene—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000667	0.00202	CcSEcCtD
Dantrolene—Nausea—Galantamine—Alzheimer's disease	0.000663	0.002	CcSEcCtD
Dantrolene—Fatigue—Rivastigmine—Alzheimer's disease	0.000662	0.002	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000659	0.00325	CbGpPWpGaD
Dantrolene—Pain—Rivastigmine—Alzheimer's disease	0.000657	0.00198	CcSEcCtD
Dantrolene—Constipation—Rivastigmine—Alzheimer's disease	0.000657	0.00198	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—Alzheimer's disease	0.000656	0.00324	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000655	0.00323	CbGpPWpGaD
Dantrolene—Feeling abnormal—Memantine—Alzheimer's disease	0.000647	0.00195	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000645	0.00318	CbGpPWpGaD
Dantrolene—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000642	0.00194	CcSEcCtD
Dantrolene—Hypersensitivity—Donepezil—Alzheimer's disease	0.000637	0.00192	CcSEcCtD
Dantrolene—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000633	0.00191	CcSEcCtD
Dantrolene—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000628	0.0019	CcSEcCtD
Dantrolene—Urticaria—Memantine—Alzheimer's disease	0.000624	0.00188	CcSEcCtD
Dantrolene—Abdominal pain—Memantine—Alzheimer's disease	0.00062	0.00188	CcSEcCtD
Dantrolene—Body temperature increased—Memantine—Alzheimer's disease	0.00062	0.00188	CcSEcCtD
Dantrolene—Asthenia—Donepezil—Alzheimer's disease	0.00062	0.00187	CcSEcCtD
Dantrolene—Pruritus—Donepezil—Alzheimer's disease	0.000612	0.00185	CcSEcCtD
Dantrolene—Urticaria—Rivastigmine—Alzheimer's disease	0.00061	0.00184	CcSEcCtD
Dantrolene—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000607	0.00183	CcSEcCtD
Dantrolene—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000607	0.00183	CcSEcCtD
Dantrolene—Diarrhoea—Donepezil—Alzheimer's disease	0.000591	0.00179	CcSEcCtD
Dantrolene—Hypersensitivity—Memantine—Alzheimer's disease	0.000578	0.00175	CcSEcCtD
Dantrolene—Dizziness—Donepezil—Alzheimer's disease	0.000572	0.00173	CcSEcCtD
Dantrolene—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000566	0.00171	CcSEcCtD
Dantrolene—Asthenia—Memantine—Alzheimer's disease	0.000563	0.0017	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—Alzheimer's disease	0.000558	0.00275	CbGpPWpGaD
Dantrolene—Pruritus—Memantine—Alzheimer's disease	0.000555	0.00168	CcSEcCtD
Dantrolene—Asthenia—Rivastigmine—Alzheimer's disease	0.000551	0.00166	CcSEcCtD
Dantrolene—Vomiting—Donepezil—Alzheimer's disease	0.00055	0.00166	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000549	0.00271	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000548	0.0027	CbGpPWpGaD
Dantrolene—Rash—Donepezil—Alzheimer's disease	0.000545	0.00165	CcSEcCtD
Dantrolene—Dermatitis—Donepezil—Alzheimer's disease	0.000545	0.00165	CcSEcCtD
Dantrolene—Pruritus—Rivastigmine—Alzheimer's disease	0.000543	0.00164	CcSEcCtD
Dantrolene—Headache—Donepezil—Alzheimer's disease	0.000542	0.00164	CcSEcCtD
Dantrolene—Diarrhoea—Memantine—Alzheimer's disease	0.000537	0.00162	CcSEcCtD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000527	0.0026	CbGpPWpGaD
Dantrolene—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000525	0.00159	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000521	0.00257	CbGpPWpGaD
Dantrolene—Dizziness—Memantine—Alzheimer's disease	0.000519	0.00157	CcSEcCtD
Dantrolene—Nausea—Donepezil—Alzheimer's disease	0.000513	0.00155	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000513	0.00253	CbGpPWpGaD
Dantrolene—Dizziness—Rivastigmine—Alzheimer's disease	0.000508	0.00153	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000506	0.0025	CbGpPWpGaD
Dantrolene—Vomiting—Memantine—Alzheimer's disease	0.000499	0.00151	CcSEcCtD
Dantrolene—Rash—Memantine—Alzheimer's disease	0.000495	0.0015	CcSEcCtD
Dantrolene—Dermatitis—Memantine—Alzheimer's disease	0.000494	0.00149	CcSEcCtD
Dantrolene—Headache—Memantine—Alzheimer's disease	0.000492	0.00149	CcSEcCtD
Dantrolene—Vomiting—Rivastigmine—Alzheimer's disease	0.000488	0.00148	CcSEcCtD
Dantrolene—Rash—Rivastigmine—Alzheimer's disease	0.000484	0.00146	CcSEcCtD
Dantrolene—Dermatitis—Rivastigmine—Alzheimer's disease	0.000484	0.00146	CcSEcCtD
Dantrolene—Headache—Rivastigmine—Alzheimer's disease	0.000481	0.00145	CcSEcCtD
Dantrolene—Nausea—Memantine—Alzheimer's disease	0.000466	0.00141	CcSEcCtD
Dantrolene—Nausea—Rivastigmine—Alzheimer's disease	0.000456	0.00138	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—Alzheimer's disease	0.000443	0.00219	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000426	0.0021	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000416	0.00205	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000384	0.00189	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000378	0.00187	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—Alzheimer's disease	0.000327	0.00161	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000311	0.00153	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000281	0.00139	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000248	0.00122	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000227	0.00112	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000224	0.00111	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000221	0.00109	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000218	0.00107	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000188	0.000927	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000184	0.000909	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000178	0.000878	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000132	0.00065	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	9.98e-05	0.000493	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	9.79e-05	0.000483	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.66e-05	0.000476	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.66e-05	0.000279	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.81e-05	0.000237	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.52e-05	0.000223	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.29e-05	0.000212	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.09e-05	0.000202	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.92e-05	0.000194	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.78e-05	0.000186	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.65e-05	0.00018	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.35e-05	0.000116	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.35e-05	0.000116	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.25e-05	0.000111	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.17e-05	0.000107	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.09e-05	0.000103	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.82e-05	8.99e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.8e-05	8.89e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.71e-05	8.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.71e-05	8.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.67e-05	8.26e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.59e-05	7.83e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.5e-05	7.39e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.45e-05	7.16e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.25e-05	6.17e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.25e-05	6.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.14e-05	5.62e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	5.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.58e-06	4.73e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.55e-06	4.71e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.46e-06	4.67e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.32e-06	4.1e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INS—Alzheimer's disease	8.16e-06	4.02e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.15e-06	3.53e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.54e-06	3.23e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.29e-06	1.62e-05	CbGpPWpGaD
